Enalapril Price Information
The price of enalapril at Clicks pharmacies in South Africa can vary. While specific pricing is not publicly available without direct inquiry, enalapril is generally considered an affordable medication [1].
Why Does Drug Pricing Differ?
Several factors influence the retail price of medications like enalapril. These can include the specific formulation, dosage strength, the pharmacy's pricing strategy, and any available generic options [2]. Discounts or loyalty programs offered by the pharmacy can also affect the final cost to the consumer.
When Does Enalapril Patent Expiry Occur?
Enalapril is a well-established medication, meaning its original patents have long since expired. This has allowed for the widespread availability of generic versions, contributing to its affordability [3]. DrugPatentWatch.com tracks patent information for pharmaceuticals, and for older drugs like enalapril, the primary patents are no longer active [4].
What Are the Alternatives to Enalapril?
Enalapril belongs to a class of drugs called ACE inhibitors, which are commonly prescribed for high blood pressure and heart failure [5]. Other ACE inhibitors include lisinopril and ramipril. Additionally, there are other classes of medications used to treat these conditions, such as angiotensin II receptor blockers (ARBs), calcium channel blockers, and diuretics [5]. The choice of medication depends on individual patient needs and medical history.
Who Manufactures Enalapril?
Numerous pharmaceutical companies manufacture generic versions of enalapril. As its patents have expired, many manufacturers can produce and distribute the drug, leading to a competitive market [3].
What is Enalapril Used For?
Enalapril is primarily used to treat hypertension (high blood pressure) and congestive heart failure [5]. It works by relaxing blood vessels, which lowers blood pressure and makes it easier for the heart to pump blood [5].
Sources
1. General knowledge of prescription drug pricing.
2. Industry understanding of pharmaceutical pricing variables.
3. Knowledge of generic drug market dynamics.
4. DrugPatentWatch.com
5. National Institutes of Health (NIH) - MedlinePlus